Growth Inhibition of Candida Albicans by Interleukin-2-activated Splenocytes

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1992 Mar 1

PMID 1541559

Citations 12

Authors

D W Beno

H L Mathews

Affiliations

Soon will be listed here.

Abstract

Murine splenocytes, Percoll-enriched low-density lymphocytes, and interleukin-2 (IL-2)-activated lymphocytes were assessed for the capacity to limit the growth of the hyphal form of Candida albicans. No fungal-growth-inhibitory activity was exhibited for C. albicans by either splenocytes or Percoll-enriched lymphocytes. These cells were capable of cytotoxic activity for a natural killer cell-sensitive cell line. However, when cultured for several days with IL-2, splenocytes acquired the capacity to inhibit the growth of the fungus. The appearance of the antifungal activity coincided with the development of cytotoxic activity for the natural killer cell-insensitive cell line. Anti-C. albicans and antitumor activities of IL-2-activated lymphocytes were competitively and reciprocally inhibited by C. albicans and the natural killer cell-sensitive and -insensitive cell lines. The antifungal activity of the IL-2-activated lymphocytes was exhibited against a number of clinical isolates of C. albicans and related fungal species. IL-2-activated human peripheral blood lymphocytes also acquired the capacity to inhibit the growth of C. albicans. These data show that in vitro growth inhibition can be mediated by IL-2-stimulated lymphocytes which are neither fungal strain nor mammalian species restricted in their biological activity.

Citing Articles

Juice Shows Anti-Fungal Efficacy in Experimental Oral Candidiasis in Immunosuppressed Rats in Relation to Its Chemical Profile.

El-Newary S, Abd Elkarim A, Abdelwahed N, Omer E, Elgamal A, Elsayed W Molecules. 2023; 28(11).

PMID: 37298777 PMC: 10254659. DOI: 10.3390/molecules28114304.

can foster gut dysbiosis and systemic inflammation during HIV infection.

Zaongo S, Ouyang J, Isnard S, Zhou X, Harypursat V, Cui H Gut Microbes. 2023; 15(1):2167171.

PMID: 36722096 PMC: 9897780. DOI: 10.1080/19490976.2023.2167171.

Early expression of local cytokines during systemic infection in a murine intravenous challenge model.

Chin V, Foong K, Maha A, Rusliza B, Norhafizah M, Chong P Biomed Rep. 2014; 2(6):869-874.

PMID: 25279161 PMC: 4179772. DOI: 10.3892/br.2014.365.

Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis.

Fidel Jr P Adv Dent Res. 2011; 23(1):45-9.

PMID: 21441480 PMC: 3144040. DOI: 10.1177/0022034511399284.

Direct microbicidal activity of cytotoxic T-lymphocytes.

Oykhman P, Mody C J Biomed Biotechnol. 2010; 2010:249482.

PMID: 20617144 PMC: 2896662. DOI: 10.1155/2010/249482.

References

Yamamura M, Boler J, Valdimarsson H . Phagocytosis measured as inhibition of uridine uptake by Candida albicans. J Immunol Methods. 1977; 14(1):19-24. DOI: 10.1016/s0022-1759(97)90016-8. View

Pross H, Baines M, Rubin P, Shragge P, Patterson M . Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol. 1981; 1(1):51-63. DOI: 10.1007/BF00915477. View

Herberman R, HOLDEN H . Natural cell-mediated immunity. Adv Cancer Res. 1978; 27:305-77. DOI: 10.1016/s0065-230x(08)60936-7. View

Bouchara J, Tronchin G, Annaix V, Robert R, Senet J . Laminin receptors on Candida albicans germ tubes. Infect Immun. 1990; 58(1):48-54. PMC: 258407. DOI: 10.1128/iai.58.1.48-54.1990. View

Ashman R . Murine candidiasis: cell-mediated immune responses correlate directly with susceptibility and resistance to infection. Immunol Cell Biol. 1990; 68 ( Pt 1):15-20. DOI: 10.1038/icb.1990.2. View

Beno D, Mathews H . Growth inhibition of Candida albicans by interleukin-2-induced lymph node cells. Cell Immunol. 1990; 128(1):89-100. DOI: 10.1016/0008-8749(90)90009-g. View

Hidore M, Nabavi N, Reynolds C, Henkart P, Murphy J . Cytoplasmic components of natural killer cells limit the growth of Cryptococcus neoformans. J Leukoc Biol. 1990; 48(1):15-26. DOI: 10.1002/jlb.48.1.15. View

Miller M, Mitchell T, Storkus W, Dawson J . Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody. Infect Immun. 1990; 58(3):639-45. PMC: 258513. DOI: 10.1128/iai.58.3.639-645.1990. View

Djeu J, Blanchard D . Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor. J Immunol. 1987; 139(8):2761-7. View

10.

Mule J, Krosnick J, Rosenberg S . IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors. J Immunol. 1989; 142(2):726-33. View

11.

Yang J, Mule J, Rosenberg S . Murine lymphokine-activated killer (LAK) cells: phenotypic characterization of the precursor and effector cells. J Immunol. 1986; 137(2):715-22. View

12.

Lafreniere R, Rosenstein M, Rosenberg S . Optimal methods for generating expanded lymphokine activated killer cells capable of reducing established murine tumors in vivo. J Immunol Methods. 1986; 94(1-2):37-49. DOI: 10.1016/0022-1759(86)90213-9. View

13.

Peace D, Kern D, Schultz K, Greenberg P, Cheever M . IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes. J Immunol. 1988; 140(10):3679-85. View

14.

Ortaldo J, Longo D . Human natural lymphocyte effector cells: definition, analysis of activity, and clinical effectiveness. J Natl Cancer Inst. 1988; 80(13):999-1010. DOI: 10.1093/jnci/80.13.999. View

15.

Djeu J, Blanchard D, Richards A, Friedman H . Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. J Immunol. 1988; 141(11):4047-52. View

16.

Lanier L, Le A, Civin C, Loken M, Phillips J . The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol. 1986; 136(12):4480-6. View

17.

Ausiello C, Maleci A, Spagnoli G, Antonelli G, Cassone A . Cell-mediated cytotoxicity in glioma-bearing patients: differential responses of peripheral blood mononuclear cells to stimulation with interleukin-2 and microbial antigen. J Neurooncol. 1988; 6(4):329-38. DOI: 10.1007/BF00177428. View

18.

Mahanty S, Greenfield R, Joyce W, Kincade P . Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome. Infect Immun. 1988; 56(12):3162-6. PMC: 259718. DOI: 10.1128/iai.56.12.3162-3166.1988. View

19.

Zunino S, Hudig D . Interactions between human natural killer (NK) lymphocytes and yeast cells: human NK cells do not kill Candida albicans, although C. albicans blocks NK lysis of K562 cells. Infect Immun. 1988; 56(3):564-9. PMC: 259327. DOI: 10.1128/iai.56.3.564-569.1988. View

20.

Merluzzi V, Smith M . Similarities and distinctions between murine natural killer cells and lymphokine-activated killer cells. Cell Immunol. 1986; 100(2):563-9. DOI: 10.1016/0008-8749(86)90054-7. View